← Leaderboards
Harvey Allen Schenkein
Gordon Research Conferences
$4,433,809
Attributed
$4,433,809
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $682.9K · FY2008–20$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$11,087,566 · 11
By mechanism
P01$5,194,938 · 4
R01$3,655,206 · 2
U19$2,212,422 · 4
R13$25,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Periodontitis”
- Georgios Hajishengallis · University Of Pennsylvania$28,284,116
- Richard J Lamont · Research Inst Nationwide Children'S Hosp$23,766,749
- Salomon Amar · Boston Medical Center$18,335,188
- Thomas E Van Dyke · Boston University Medical Campus$17,793,622
- Steven Nmn Offenbacher · University Of North Carolina Chapel Hill$17,786,424
- Ricardo P Teles · Beth Israel Deaconess Medical Center$17,089,524
Research focus
PeriodontitisHuman SubjectPeriodontium DisorderClinical ResearchBactericidal ImmunityCytokineActinobacillus ActinomycetemcomitansProductionAtherosclerosisPorphyromonas GingivalisResponseInflammationImmunoglobulin GChronicSerumCardiovascular DiseasesImmunoglobulin MAntibody FormationLinkVascular InflammationCell Adhesion MoleculesGlycoproteinsIn VitroEndothelial Cells
Grant awards (28)
Antiphospholipids in periodontitis$381,250
R01 · FY2020 · DE · contact PI
Antiphospholipids in periodontitis$381,250
R01 · FY2019 · DE · contact PI
Antiphospholipids in periodontitis$381,250
R01 · FY2018 · DE · contact PI
Antiphospholipids in periodontitis$381,250
R01 · FY2017 · DE · contact PI
Antiphospholipids in periodontitis$381,250
R01 · FY2016 · DE · contact PI
Antiphospholipids and vascular inflammation in aggressive periodontitis$346,979
R01 · FY2011 · DE · contact PI
Antiphospholipids and vascular inflammation in aggressive periodontitis$357,712
R01 · FY2010 · DE · contact PI
Antiphospholipids and vascular inflammation in aggressive periodontitis$361,325
R01 · FY2009 · DE · contact PI
Periodontitis, Anti-phospholipids, Dendritic Cells, and Atherosclerosis$321,615
R01 · FY2009 · DE · contact PI
Antiphospholipids and vascular inflammation in aggressive periodontitis$361,325
R01 · FY2008 · DE · contact PI
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES$1,554,160
P01 · FY2004 · DE
ANTIBODY REACTIVITY TO PHOSPHORYLCHOLINE$174,558
P01 · FY2004 · DE
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES$1,531,125
P01 · FY2003 · DE
ANTIBODY REACTIVITY TO PHOSPHORYLCHOLINE$149,072
P01 · FY2003 · DE
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES$1,003,754
P01 · FY2002 · DE
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES$637,540
P01 · FY2002 · DE
ANTIBODY REACTIVITY TO PHOSPHORYLCHOLINE$144,729
P01 · FY2002 · DE
CORE--BIOSTATISTICS$0
P01 · FY2002 · DE
CORE--CLINICAL$0
P01 · FY2002 · DE
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES$974,515
U19 · FY2001 · DE
ANTIBODY REACTIVITY TO PHOSPHORYLCHOLINE$140,515
U19 · FY2001 · DE
CORE--BIOSTATISTICS$0
U19 · FY2001 · DE
CORE--CLINICAL$0
U19 · FY2001 · DE
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES$952,663
U19 · FY2000 · DE
ANTIBODY REACTIVITY TO PHOSPHORYLCHOLINE$144,729
U19 · FY2000 · DE
GORDON RESEARCH CONFERENCE ON PERIODONTAL DISEASE$25,000
R13 · FY2000 · DE
CORE--BIOSTATISTICS$0
U19 · FY2000 · DE
CORE--CLINICAL$0
U19 · FY2000 · DE